Hans W Jeuring1, Max L Stek2, Martijn Huisman3, Richard C Oude Voshaar4, Paul Naarding5, Rose M Collard6, Roos C van der Mast7, Rob M Kok8, Aartjan T F Beekman2, Hannie C Comijs2. 1. Department of Psychiatry, GGZ in Geest, VU University Medical Center, Amsterdam, The Netherlands; Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, The Netherlands. Electronic address: h.jeuring@vumc.nl. 2. Department of Psychiatry, GGZ in Geest, VU University Medical Center, Amsterdam, The Netherlands; Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, The Netherlands. 3. Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, The Netherlands. 4. University Center for Psychiatry, University Medical Center Groningen, Groningen, The Netherlands. 5. GGNet, Department of Old Age Psychiatry, Apeldoorn, The Netherlands. 6. Radboud University Medical Center, Department of Psychiatry, Nijmegen, The Netherlands. 7. Department of Psychiatry, Leiden University Medical Center, Leiden, The Netherlands; Collaborative Antwerp Psychiatric Research Institute (CAPRI), University of Antwerp, Antwerp, Belgium. 8. Parnassia Psychiatric Institute, Hague, The Netherlands.
Abstract
OBJECTIVES: To examine the six-year prognosis of patients with late-life depression and to identify prognostic factors of an unfavorable course. DESIGN AND SETTING: The Netherlands Study of Depression in Older Persons (NESDO) is a multisite naturalistic prospective cohort study with six-year follow-up. PARTICIPANTS: Three hundred seventy-eight clinically depressed patients (according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition Text Revision criteria) and 132 nondepressed comparisons were included at baseline between 2007 and 2010. MEASUREMENTS: Depression was measured by the Inventory of Depressive Symptomatology at 6-month intervals and a diagnostic interview at 2- and 6-year follow-up. Multinomial regression and mixed model analyses were both used to identify depression-related clinical, health, and psychosocial prognostic factors of an unfavorable course. RESULTS: Among depressed patients at baseline, 46.8% were lost to follow-up; 15.9% had an unfavorable course, i.e., chronic or recurrent; 24.6% had partial remission; and 12.7% had full remission at six-year follow-up. The relative risk of mortality in depressed patients was 2.5 (95% confidence interval 1.26-4.81) versus nondepressed comparisons. An unfavorable course of depression was associated with a younger age at depression onset; higher symptom severity of depression, pain, and neuroticism; and loneliness at baseline. Additionally, partial remission was associated with chronic diseases and loneliness at baseline when compared with full remission. CONCLUSIONS: The long-term prognosis of late-life depression is poor with regard to mortality and course of depression. Chronic diseases, loneliness, and pain may be used as putative targets for optimizing prevention and treatment strategies for relapse and chronicity.
OBJECTIVES: To examine the six-year prognosis of patients with late-life depression and to identify prognostic factors of an unfavorable course. DESIGN AND SETTING: The Netherlands Study of Depression in Older Persons (NESDO) is a multisite naturalistic prospective cohort study with six-year follow-up. PARTICIPANTS: Three hundred seventy-eight clinically depressedpatients (according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition Text Revision criteria) and 132 nondepressed comparisons were included at baseline between 2007 and 2010. MEASUREMENTS: Depression was measured by the Inventory of Depressive Symptomatology at 6-month intervals and a diagnostic interview at 2- and 6-year follow-up. Multinomial regression and mixed model analyses were both used to identify depression-related clinical, health, and psychosocial prognostic factors of an unfavorable course. RESULTS: Among depressedpatients at baseline, 46.8% were lost to follow-up; 15.9% had an unfavorable course, i.e., chronic or recurrent; 24.6% had partial remission; and 12.7% had full remission at six-year follow-up. The relative risk of mortality in depressedpatients was 2.5 (95% confidence interval 1.26-4.81) versus nondepressed comparisons. An unfavorable course of depression was associated with a younger age at depression onset; higher symptom severity of depression, pain, and neuroticism; and loneliness at baseline. Additionally, partial remission was associated with chronic diseases and loneliness at baseline when compared with full remission. CONCLUSIONS: The long-term prognosis of late-life depression is poor with regard to mortality and course of depression. Chronic diseases, loneliness, and pain may be used as putative targets for optimizing prevention and treatment strategies for relapse and chronicity.
Authors: Ángel Rodríguez-Ramos; Juan Antonio Moriana; Francisco García-Torres; Manuel Ruiz-Rubio Journal: Brain Behav Date: 2019-08-25 Impact factor: 2.708
Authors: Akihiro Takamiya; Thomas Vande Casteele; Michel Koole; François-Laurent De Winter; Filip Bouckaert; Jan Van den Stock; Stefan Sunaert; Patrick Dupont; Rik Vandenberghe; Koen Van Laere; Mathieu Vandenbulcke; Louise Emsell Journal: Sci Rep Date: 2021-08-05 Impact factor: 4.379
Authors: Bart Meuleman; Janna N Vrijsen; Marie-Anne Vanderhasselt; Ernst H W Koster; Peter Oostelbos; Paul Naarding; Linda Bolier; Indira Tendolkar; Filip Smit; Jan Spijker; Eni S Becker Journal: BMC Psychiatry Date: 2021-11-27 Impact factor: 3.630
Authors: Carlijn Wiersema; Richard C Oude Voshaar; Rob H S van den Brink; Hans Wouters; Peter Verhaak; Hannie C Comijs; Hans W Jeuring Journal: Acta Psychiatr Scand Date: 2022-04-29 Impact factor: 7.734
Authors: Agnieszka Boroń; Małgorzata Śmiarowska; Anna Grzywacz; Krzysztof Chmielowiec; Jolanta Chmielowiec; Jolanta Masiak; Tomasz Pawłowski; Dariusz Larysz; Andrzej Ciechanowicz Journal: Int J Environ Res Public Health Date: 2022-08-12 Impact factor: 4.614
Authors: K J E Kokkeler; R M Marijnissen; K J Wardenaar; D Rhebergen; R H S van den Brink; R C van der Mast; R C Oude Voshaar Journal: Psychol Med Date: 2020-07-03 Impact factor: 7.723